Cancer is the number two cause of death worldwide, and despite 100s of billions invested, there is still no cure, only treatments. The treatments we do have such as chemotherapy, radiation, and surgery, while extremely aggressive, work very well if detection is early. Since there are dozens of types of cancer, screening and detection has proven challenging–but that might be changing. My guest on this week’s podcast is on the forefront of genomic medicine and hopes to make early screen accessible to everyone.
Listen and learn:
- How new technology allows for blood plasma scanning of cell-free DNA (cfDNA) to find tiny particles from cancers
- The role of full body MRI in cancer screening
- Why it currently costs thousands per year but could end up costing a fraction of this in the future
Links
www.GetSerenity.life
ABOUT OUR GUEST
Jo Bhakdi is the Founder and CEO of Quantgene, a precision genomics and oncology company founded in 2015. Quantgene's goal is to build the future of medicine by utilizing advanced scientific and technological innovations.
Like the Show?
